Morgan Stanley Bioceres Crop Solutions Corp. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Bioceres Crop Solutions Corp. stock. As of the latest transaction made, Morgan Stanley holds 69,649 shares of BIOX stock, worth $479,881. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,649
Previous 69,649
-0.0%
Holding current value
$479,881
Previous $780,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BIOX
# of Institutions
51Shares Held
14MCall Options Held
400Put Options Held
9.6K-
Solel Partners LP Boston, MA4.58MShares$31.6 Million7.32% of portfolio
-
Fourth Sail Capital LP Camana Bay Grand Cayman, E93.17MShares$21.8 Million6.27% of portfolio
-
Polar Capital Holdings PLC London, X01.65MShares$11.4 Million0.08% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.58MShares$10.9 Million2.2% of portfolio
-
Ballast Asset Management, LP Dallas, TX350KShares$2.41 Million1.41% of portfolio
About Bioceres Crop Solutions Corp.
- Ticker BIOX
- Exchange NASDAQ
- Sector Basic Materials
- Industry Agricultural Inputs
- Shares Outstandng 61,918,400
- Market Cap $427M
- Description
- Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. ...